Get the Stockscreener App
1.50
0.00%
0.00
After Hours:
1.50
Cardlytics Inc stock is traded at $1.50, with a volume of 1.19M.
It is up +0.00% in the last 24 hours and down -36.97% over the past month.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.
See More
Previous Close:
$1.50
Open:
$1.5
24h Volume:
1.19M
Relative Volume:
1.16
Market Cap:
$73.57M
Revenue:
$278.30M
Net Income/Loss:
$-189.30M
P/E Ratio:
-0.3886
EPS:
-3.86
Net Cash Flow:
$-28.12M
1W Performance:
+7.14%
1M Performance:
-36.97%
6M Performance:
-62.03%
1Y Performance:
-87.68%
1-Day Range:
$1.46
$1.56
1-Week Range:
$1.3301
$1.59
52-Week Range:
$1.22
$15.89
Cardlytics Inc Stock (CDLX) Company Profile
Name
Cardlytics Inc
Sector
Industry
Phone
888-798-5802
Address
675 PONCE DE LEON AVENUE, NE, ATLANTA, GA
Compare CDLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDLX
Cardlytics Inc
|
1.50 | 73.57M | 278.30M | -189.30M | -28.12M | -3.86 |
|
OMC
Omnicom Group Inc
|
73.24 | 14.99B | 15.43B | 1.37B | 1.50B | 7.32 |
|
IPG
Interpublic Group Of Cos Inc
|
23.94 | 9.32B | 10.86B | 808.20M | 922.50M | 2.12 |
|
WPP
Wpp Plc Adr
|
35.66 | 7.84B | 18.59B | 256.66M | 1.13B | 1.1736 |
|
CRTO
Criteo S A Adr
|
29.90 | 1.52B | 1.96B | 102.18M | 144.20M | 1.72 |
|
STGW
Stagwell Inc
|
5.43 | 1.40B | 2.61B | 137.00K | 102.37M | -0.0274 |
Cardlytics Inc Stock (CDLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-11-24 | Initiated | Evercore ISI | In-line |
| Aug-16-24 | Downgrade | Northland Capital | Outperform → Market Perform |
| Aug-15-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-08-24 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-08-24 | Downgrade | Lake Street | Buy → Hold |
| Aug-08-24 | Downgrade | Needham | Buy → Hold |
| Jun-20-24 | Resumed | BofA Securities | Neutral |
| Jun-18-24 | Initiated | Northland Capital | Outperform |
| Mar-15-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-29-23 | Initiated | Lake Street | Buy |
| Sep-08-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jul-14-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-12-22 | Downgrade | Craig Hallum | Buy → Hold |
| Apr-05-22 | Resumed | Wells Fargo | Overweight |
| Jun-18-21 | Initiated | Needham | Buy |
| Apr-15-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-14-21 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-05-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-14-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-28-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-21-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Mar-04-20 | Downgrade | Craig Hallum | Buy → Hold |
| Jan-15-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-02-19 | Initiated | Craig Hallum | Buy |
| Nov-14-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-09-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jul-24-19 | Reiterated | BofA/Merrill | Buy |
| Jul-01-19 | Initiated | William Blair | Outperform |
| Jan-15-19 | Upgrade | BofA/Merrill | Neutral → Buy |
View All
Cardlytics Inc Stock (CDLX) Latest News
Brokerages Set Cardlytics, Inc. (NASDAQ:CDLX) PT at $6.42 - MarketBeat
LPL Financial LLC Sells 25,467 Shares of Cardlytics, Inc. (NASDAQ:CDLX) - Defense World
Rangeley Capital LLC Buys Shares of 320,000 Cardlytics, Inc. (NASDAQ:CDLX) - MarketBeat
Why Investors Shouldn't Be Surprised By Cardlytics, Inc.'s (NASDAQ:CDLX) 30% Share Price Plunge - simplywall.st
Cardlytics CFO Alexis DeSieno sells $14,444 worth of stock - Investing.com Australia
Cardlytics stock hits 52-week low at $1.73 amid sharp decline - Investing.com Australia
Cardlytics CEO Amit Gupta sells $13,259 in stock - Investing.com Australia
Cardlytics CFO Alexis DeSieno sells $14,444 worth of stock By Investing.com - Investing.com Canada
Cardlytics stock hits 52-week low at $1.73 amid sharp decline By Investing.com - Investing.com South Africa
Cardlytics CEO Amit Gupta sells $13,259 in stock By Investing.com - Investing.com Canada
Cardlytics Executives Conduct Share Sales - TradingView
16,729 Shares in Cardlytics, Inc. (NASDAQ:CDLX) Purchased by Virtu Financial LLC - Defense World
Cardlytics, Inc. (NASDAQ:CDLX) Stock Holdings Increased by Charles Schwab Investment Management Inc. - Defense World
Payfare and Cardlytics Partner to Launch Cash Back Rewards Program - FinTech Futures
Cardlytics hooks Wells Fargo as partner - FinTech Futures
Cardlytics, Inc. (NASDAQ:CDLX) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Brokerages Set Cardlytics, Inc. (NASDAQ:CDLX) Price Target at $6.42 - Defense World
Cardlytics reports Q4 adjusted EPS 0c, consensus (20c) - MSN
Cardlytics, Inc. Class Action: Levi & Korsinsky Reminds Cardlytics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025CDLX - PR Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ESSA, Cardlytics, Novo Nordisk, and Crocs and Encourages Investors to Contact the Firm - TradingView
Lost Money on Cardlytics, Inc.(CDLX)? Join Class Action Suit Seeking RecoveryContact The Gross Law Firm - PR Newswire
Cardlytics, Inc. (NASDAQ: CDLX) Investor Alert: Deadline in Lawsuit on March 25, 2025 - openPR
March 2025 Penny Stocks Worth Watching - Simply Wall St
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Cardlytics Lawsuit – CDLX - GlobeNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ... - Bluefield Daily Telegraph
Contact Levi & Korsinsky by March 25, 2025 Deadline to Join Class Action Against Cardlytics, Inc.(CDLX) - PR Newswire
The Gross Law Firm Reminds Cardlytics, Inc. Investors of - GlobeNewswire
The Gross Law Firm Reminds Cardlytics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – CDLX - TradingView
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Cardlytics, Inc.(CDLX) Shareholders - PR Newswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics - StreetInsider.com
Cardlytics (NASDAQ:CDLX) Price Target Lowered to $3.00 at Lake Street Capital - The AM Reporter
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics - GlobeNewswire
Needham & Company LLC Reaffirms “Hold” Rating for Cardlytics (NASDAQ:CDLX) - Defense World
Lake Street Capital Lowers Cardlytics (NASDAQ:CDLX) Price Target to $3.00 - Defense World
Evercore ISI Lowers Cardlytics (NASDAQ:CDLX) Price Target to $3.00 - Defense World
CDLX INVESTORS: Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the - Bluefield Daily Telegraph
CDLX INVESTORS: Contact Robbins LLP for Information About - GlobeNewswire
CDLX INVESTORS: Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the Class Action Against Cardlytics, Inc. - TradingView
Lake Street Capital Issues Pessimistic Forecast for Cardlytics (NASDAQ:CDLX) Stock Price - MarketBeat
Cardlytics (NASDAQ:CDLX) Price Target Lowered to $3.00 at Evercore ISI - MarketBeat
Cardlytics Full Year 2024 Earnings: Beats Expectations - Yahoo
Cardlytics, Inc. Navigates Mixed Earnings Call - TipRanks
Cardlytics (NASDAQ:CDLX) Releases Quarterly Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat
Cardlytics (NASDAQ:CDLX) Posts Quarterly Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat
Shareholders that lost money on Cardlytics, Inc. (CDLX) Urged to Join Class Action – Contact - Bluefield Daily Telegraph
Shareholders that lost money on Cardlytics, Inc. (CDLX) - GlobeNewswire
Cardlytics stock price target cut to $3 at Craig-Hallum By Investing.com - Investing.com Australia
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics - The Malaysian Reserve
Evercore ISI cuts Cardlytics stock target to $3, maintains rating By Investing.com - Investing.com UK
Cardlytics Inc Stock (CDLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cardlytics Inc Stock (CDLX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DeSieno Alexis | Chief Financial Officer |
Apr 02 '25 |
Sale |
1.81 |
7,998 |
14,444 |
147,300 |
| Lynton Nicholas Hollmeyer | Chief Legal & Privacy Officer |
Apr 02 '25 |
Sale |
1.81 |
5,754 |
10,392 |
101,740 |
2.62%
1.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):